Clinical trials regulatory approval timeliness rate
RecordSTO-T3CXFB2BQR-JRCBTF1RHG-A9JZF2
United Kingdom · as of 8 Sep 2026
Clinical trials regulatory approval timeliness rate in the United Kingdom was 98% (ABPI, published 8 September 2026).
Clinical trials regulatory approval timeliness rate: every country and year, and how it is measured
- Publisher
- ABPI
- Authority tier
- T2 Official
- Locator
- UK areas of unrealised potential
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Study set-up has improved, with 98 per cent of trials receiving regulatory approval within 60 days, though patient recruitment continues to decline and requires attention across the whole trial journey.
Checked: the figure 98%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2
Other formats: MLA, Chicago, BibTeX
- MLA
- Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026, https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2.
- Chicago
- Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026. https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2.
- BibTeX
- @misc{abpi2026clinicala9jzf2, author = {{Association of the British Pharmaceutical Industry}}, title = {Green shoots for UK pharma investment, but delivery will decide whether they take root}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2}, note = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- Association of the British Pharmaceutical Industry · homepage ↗
- Authority tier
- Tier 2 · National and industry official
- Report
- Green shoots for UK pharma investment, but delivery will decide whether they take root
- Type
- Press release
- Published
- —
- Locator
- UK areas of unrealised potential
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2